Summary
The global Warfarin Sensitivity Testing Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The use of warfarin is associated with a number of adverse effects, including excessive bleeding and an increased risk of stroke. Owing to this, physicians must first determine which dosage is appropriate for the patient. This process can take anywhere from five to seven weeks. Unfortunately, many patients may experience serious adverse events during this period. To minimize these risks, genetic testing may be a viable alternative. CYP2C9 and VKORC1 are known to influence warfarin responses. There is limited evidence to support the routine testing of these genes. However, CYP2C9 and VKORC1 gene variants are being tested in a few laboratories. While genotype data produced by these tests is more accurate, their associations with phenotypic warfarin dosing are not clear.
Drivers
The rising prevalence of blood-related illnesses, as well as technical breakthroughs in the sector, are the primary drivers driving market expansion.
Since warfarin is used to treat thrombosis, the warfarin sensitivity test market is likely to rise rapidly throughout the forecast period. According to the Centers for Disease Control and Prevention, thrombosis will kill 60,000 to 100,000 people in the United States in 2020, and around 5% to 8% of the population has a genetic abnormality.
Restraints
It's conceivable that increased knowledge of blood-related problems during big operations is stifling the market for warfarin sensitivity testing.
Regional Insights
Due to the high frequency of chronic wounds, North America is likely to lead the global warfarin sensitivity testing market.
Due to greater awareness of antibiotic resistance and safe and effective antibiotic use in the area, Europe is expected to witness significant growth in the warfarin sensitivity testing market.
Competitive Landscape
- Major companies contributing to the global warfarin sensitivity testing market include ACON Laboratories, Roche Diagnostics International, Eurolyser Diagnostica GmbH, WerfenLife, CoaguSense, Cardinal Health, Abbott, Micropoint Biosciences, and Siemens.
- In January 2022, a group of researchers from National Taiwan University completed their study on complications of diabetes, concluding that patients are less likely to develop macrovascular complications while using warfarin in lieu of conventional non-vitamin k antagonist oral anticoagulants (NOACs).
- In February 2022, according to a study conducted by the National Heart, Lung, and Blood Institute, COVID-19 patients are less likely to develop pulmonary embolism and deep venous thrombosis after receiving anticoagulation with direct oral anticoagulants (DOACs).
The Warfarin Sensitivity Testing Market report highlights product development and growth strategies such as mergers and acquisitions adopted by market players along with SWOT Analysis, PEST, and Porter’s Five Forces analyses of the Warfarin Sensitivity Testing Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- CoaguSense
- Eurolyser Diagnostica GmbH
- Roche Diagnostics International
- ACON Laboratories
- Siemens
- Micropoint Biosciences
- Abbott
- WerfenLife
- Cardinal Health
By the Product Type, the market is primarily segmented into:
- Test Analyzer
- Consumables
By Applications, the market is segmented into:
- Hospital Specialty
- Clinics Diagnostic
- Laboratory
- Others
The report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Warfarin Sensitivity Testing Market Report:
- To assess the size of the market by value and volume
- Analyze the Warfarin Sensitivity Testing Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine the share of the Warfarin Sensitivity Testing Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state–of–the–art tools and the current primary and secondary research approaches
- Discuss major factors that impact the growth of the Warfarin Sensitivity Testing Market
The Warfarin Sensitivity Testing Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Warfarin Sensitivity Testing Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type, and application, 2019 is considered the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Request Discount 
Inquire Before Buy
